(Q35907014)

11 August 2017

1 reference

title

Orally delivered malaria vaccines: not too hard to swallow (English)

1 reference

11 August 2017

0 references

1 reference

4

Ross L Coppel

1 reference

11 August 2017

3

Steven L Wesselingh

1 reference

11 August 2017

Lina Wang

1

1 reference

11 August 2017

Diane E Webster

series ordinal

2

1 reference

11 August 2017

language of work or name

English

0 references

publication date

1 October 2004

1 reference

Expert Opinion on Biological Therapy

11 August 2017

published in

1 reference

11 August 2017

volume

4

1 reference

11 August 2017

issue

10

1 reference

11 August 2017

page(s)

1585-1594

1 reference

Vaccines in historic evolution and perspective: a narrative of vaccine discoveries

11 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.10.1585

Malaria vaccine developments

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.10.1585

Vaccination strategies for mucosal immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.10.1585

Oral immunization with a recombinant malaria protein induces conformational antibodies and protects mice against lethal malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.10.1585

Immunization with recombinant Plasmodium yoelii merozoite surface protein 4/5 protects mice against lethal challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.10.1585

Cloning and analysis of the gene encoding the 230-kilodalton merozoite surface antigen of Plasmodium yoelii

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.10.1585

Characterization of the merozoite surface protein 4/5 gene of Plasmodium berghei and Plasmodium yoelii

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.10.1585

Use of live bacterial vaccine vectors for antigen delivery: potential and limitations

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.10.1585

Safety and immune responses to attenuated Salmonella enterica serovar typhi oral live vector vaccines expressing tetanus toxin fragment C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.10.1585

Salmonella: immune responses and vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.10.1585

Oral Salmonella typhimurium vaccine expressing circumsporozoite protein protects against malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.10.1585

Oral Salmonella: malaria circumsporozoite recombinants induce specific CD8+ cytotoxic T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.10.1585

Generation of a cytotoxic T-lymphocyte response using a Salmonella antigen-delivery system

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.10.1585

Expression of the Plasmodium falciparum immunodominant epitope (NANP)(4) on the surface of Salmonella enterica using the autotransporter MisL

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.10.1585

Salmonella typhi vaccine strain CVD 908 expressing the circumsporozoite protein of Plasmodium falciparum: strain construction and safety and immunogenicity in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.10.1585

Expression, extracellular secretion, and immunogenicity of the Plasmodium falciparum sporozoite surface protein 2 in Salmonella vaccine strains.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.10.1585

Surface expression of malarial antigens in Salmonella typhimurium: induction of serum antibody response upon oral vaccination of mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.10.1585

Expression of disulphide-bridge-dependent conformational epitopes and immunogenicity of the carboxy-terminal 19 kDa domain of Plasmodium yoelii merozoite surface protein-1 in live attenuated Salmonella vaccine strains

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.10.1585

Expression of fragment C of tetanus toxin fused to a carboxyl-terminal fragment of diphtheria toxin in Salmonella typhi CVD 908 vaccine strain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.10.1585

Stability, immunogenicity and expression of foreign antigens in bacterial vaccine vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.10.1585

Stable expression of foreign antigens from the chromosome of Salmonella typhimurium vaccine strains

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.10.1585

Construction of a tetR-integrated Salmonella enterica serovar Typhi CVD908 strain that tightly controls expression of the major merozoite surface protein of Plasmodium falciparum for applications in human Vaccine production

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.10.1585

Oral delivery of foreign antigens by attenuated Salmonella: consequences of prior exposure to the vector strain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.10.1585

Attenuated Shigella as a DNA delivery vehicle for DNA-mediated immunization

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.10.1585

Transfer of eukaryotic expression plasmids to mammalian host cells by bacterial carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.10.1585

Delivery of DNA vaccines by attenuated intracellular bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.10.1585

A multilateral effort to develop DNA vaccines against falciparum malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.10.1585

Antigen delivery to mucosa-associated lymphoid tissues using liposomes as a carrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.10.1585

Virosomes: evolution of the liposome as a targeted drug delivery system

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.10.1585

HBV core particles as a carrier for B cell/T cell epitopes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.10.1585

Oral immunization of adult volunteers with microencapsulated enterotoxigenic Escherichia coli (ETEC) CS6 antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.10.1585

Enteral immunization and challenge of volunteers given enterotoxigenic E. coli CFA/II encapsulated in biodegradable microspheres

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.10.1585

Recombinant Norwalk virus-like particles given orally to volunteers: phase I study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.10.1585

Immunogenicity of liposome-associated and refined antigen oral cholera vaccines in Thai volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.10.1585

Poly(DL-lactide-co-glycolide)-encapsulated plasmid DNA elicits systemic and mucosal antibody responses to encoded protein after oral administration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.10.1585

Oral DNA vaccination promotes mucosal and systemic immune responses to HIV envelope glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.10.1585

The potential of plant viral vectors and transgenic plants for subunit vaccine production

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.10.1585

Medical molecular farming: production of antibodies, biopharmaceuticals and edible vaccines in plants

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.10.1585

The production of recombinant pharmaceutical proteins in plants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.10.1585

Delivery of subunit vaccines in maize seed.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.10.1585

Overexpression of the Bt cry2Aa2 operon in chloroplasts leads to formation of insecticidal crystals

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.10.1585

A plant-based multicomponent vaccine protects mice from enteric diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.10.1585

Engineering the provitamin A (beta-carotene) biosynthetic pathway into (carotenoid-free) rice endosperm

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.10.1585

Human immune responses to a novel norwalk virus vaccine delivered in transgenic potatoes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.10.1585

Expression in plants and immunogenicity of plant virus-based experimental rabies vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.10.1585

Oral immunization with hepatitis B surface antigen expressed in transgenic plants

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.10.1585

Oral immunization with a recombinant bacterial antigen produced in transgenic plants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.10.1585

Genome sequence of the human malaria parasite Plasmodium falciparum

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.10.1585

Vaccine candidate MSP-1 from Plasmodium falciparum: a redesigned 4917 bp polynucleotide enables synthesis and isolation of full-length protein from Escherichia coli and mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.10.1585

Expression of the native cholera toxin B subunit gene and assembly as functional oligomers in transgenic tobacco chloroplasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.10.1585

Milestones in chloroplast genetic engineering: an environmentally friendly era in biotechnology

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.10.1585

The role of M cells in mucosal immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.10.1585

Inherited interleukin 12 deficiency in a child with bacille Calmette-Guérin and Salmonella enteritidis disseminated infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.10.1585

Severe mycobacterial and Salmonella infections in interleukin-12 receptor-deficient patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.10.1585

Production of a fusion protein consisting of the enterotoxigenic Escherichia coli heat-labile toxin B subunit and a tuberculosis antigen in Arabidopsis thaliana.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.10.1585

Identification of a new mechanism for bacterial uptake at mucosal surfaces, which is mediated by dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.10.1585

Immune responses to dietary antigens: oral tolerance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.10.1585

Therapeutic approaches in multiple sclerosis: lessons from failed and interrupted treatment trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.10.1585

The B subunit of Escherichia coli heat labile enterotoxin abrogates oral tolerance, promoting predominantly Th2‐type immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.10.1585

Intussusception, rotavirus, and oral vaccines: summary of a workshop

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.10.1585

Safety and immunogenicity of an oral, inactivated enterotoxigenic Escherichia coli plus cholera toxin B subunit vaccine in Bangladeshi children 18–36 months of age

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.10.1585

V-1 Immunitor: oral therapeutic AIDS vaccine with prophylactic potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.10.1585

Immune effector mechanisms in malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.10.1585

A vaccine candidate from the sexual stage of human malaria that contains EGF-like domains

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.10.1585

Production of hepatitis B surface antigen in transgenic plants for oral immunization

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.10.1585

Induction of Autoimmune Diabetes by Oral Administration of Autoantigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.10.1585

10.1517/14712598.4.10.1585

21 January 2018

Identifiers

DOI

1 reference

release_7y3z5hp6tfcsjidgvv2yk6svgu

11 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/7y3z5hp6tfcsjidgvv2yk6svgu

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference